Clinical trial

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

NCT01590160

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2013-08-01Date precision: month

Registry last updated2019-11-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer - Malignant Pleural Mesotheliomaunresolved

Interventions

GanetespibDRUG

Sponsors & collaborators

University College, Londonlead sponsor

Cancer Research UKcollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01590160 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.